Possible involvement of a σ receptor subtype in the neck dystonia in rats

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 1, 1999, Pages 123-126

  Nakazawa, Minako ^a   Kobayashi, Tetsuya ^a   Matsuno, Kiyoshi ^a   Mita, Shiro ^a  

^a SANTEN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

1 Receptor subtype; 2 Receptor subtype; DTG; Neck dystonia; Red nucleus; SA4503

Indexed keywords

1 (3,4 DIMETHOXYPHENETHYL) 4 (3 PHENYLPROPYL)PIPERAZINE; 1,3 BIS(2 METHYLPHENYL)GUANIDINE; RECEPTOR SUBTYPE; SIGMA OPIATE RECEPTOR; SIGMA RECEPTOR LIGAND;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DYSTONIA; INTRACEREBRAL DRUG ADMINISTRATION; MALE; MICROINJECTION; NECK MUSCLE; NONHUMAN; PRIORITY JOURNAL; RAT; RED NUCLEUS;

ANIMALS; DYSTONIA; GUANIDINES; MALE; MICROINJECTIONS; NECK; PIPERAZINES; RATS; RATS, WISTAR; RECEPTORS, SIGMA; RED NUCLEUS; TIME FACTORS;

EID: 0032926875     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00146-4     Document Type: Article

References (29)

1. Bowen W.D., Walker J.M., Yashar A.G., Matsumoto R.R., Walker F.O., Lorden J.F. Altered haloperidol-sensitive σ receptors in the genetically dystonic (dt) rat. Eur. J. Pharmacol. 147:1988;153-154.
2. De Coster M.A., Klette K.L., Knight E.S., Tortella F.C. σ Receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures. Brain Res. 671:1995;45-53.
3. 3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. J. Neurosci. 6:1992;1757-1770.
4. Hellewell S.B., Bowen W.D. A σ-like binding site in rat pheochromocytoma (PC12) cells. Decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different σ receptor form from that of guinea pig brain Brain Res. 527:1990;224-253.
5. + channel of class III antiarrhythmic drug? Eur. J. Pharmacol. 241:1993;111-116.
6. 1 receptor agonist, in the rat brain. J. Pharmacol. Exp. Ther. 279:1996;106-113.
7. 3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. J. Pharmacol. Exp. Ther. 238:1986;739-748.
8. Martin W.R., Eades C.G., Thompson J.A., Huppeler R.E., Gilbert P.E. The effects of morphine- and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:1976;517-532.
9. Matsumoto R.R., Bowen W.D., Tom M.A., Vo V.N., Truong D.D., De Costa B.R. Characterization of two novel σ receptor ligands. Antidystonic effects in rats suggest σ receptor antagonism Eur. J. Pharmacol. 280:1995;301-310.
10. Matsumoto R.R., Hemstreet M.K., Lai N.L., Thurkauf A., De Costa B.R., Rice K.C., Hellewell S.B., Bowen W.D., Walker J.M. Drug specificity of pharmacological dystonia. Pharmacol. Biochem. Behav. 36:1990;151-155.
11. 1 Receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test. Eur. J. Pharmacol. 312:1996;267-271.
12. Matsuno K., Matsunaga K., Mita S. Increase of extracellular acetylcholine level in rat frontal cortex induced by (+)N-allylnormetazocine as measured by brain microdialysis. Brain Res. 575:1992;315-319.
13. Matsuno K., Matsunaga K., Senda T., Mita S. Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex. J. Pharmacol. Exp. Ther. 265:1993;851-859.
14. 1 receptor agonist. Eur. J. Pharmacol. 306:1996;271-279.
15. 1 receptor in (+)-N-allylnormetazocine-stimulated hippocampal cholinergic functions in rats. Brain Res. 690:1995;200-206.
16. 1 receptor agonistic properties. Behav. Brain Res. 83:1997;221-224.
17. Matsuno K., Senda T., Matsunaga K., Mita S. Ameliorating effects of σ receptor ligands on the impairment of passive avoidance tasks in mice. Involvement in the central acetylcholinergic system Eur. J. Pharmacol. 261:1994;43-51.
18. 1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures. Neurochem. Int. 32:1998;337-343.
19. Okumura K., Ujike H., Akiyama K., Kuroda S. BMY-14802 reversed the σ receptor agonist-induced neck dystonia in rats. J. Neural Transm. 103:1996;1153-1161.
20. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2:1986;Academic Press, New York.
21. Quirion R., Chicheportiche R., Contreras P.C., Johnson K.M., Lodge D., Tam S.W., Woods J.H., Zukin S.R. Classification and nomenclature of phencyclidine and sigma receptor sites. Trends Neurosci. 10:1987;444-446.
22. Quirion R., Bowen W.D., Itzhak Y., Junien J.L., Musacchio J.M., Rothman R.B., Su T.-P., Tam S.W., Taylor D.P. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13:1992;85-86.
23. Senda T., Matsuno K., Kobayashi T., Mita S. Reduction of the scopolamine-induced impairment of passive avoidance performance by σ receptor agonist in mice. Physiol. Behav. 61:1997;257-264.
24. Senda T., Matsuno K., Kobayashi T., Nakazawa M., Nakata K., Mita S. Ameliorative effect of SA4503, a novel cognitive enhancer, on the basal forebrain-lesion-induced impairment of the spatial learning performance in rats. Pharmacol. Biochem. Behav. 59:1998;129-134.
25. 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. Eur. J. Pharmacol. 315:1996;1-10.
26. 2 receptors in motor function. Eur. J. Pharmacol. 231:1993;61-68.
27. Walker J.M., Bowen W.D., Walker F.O., Matsumoto R.R., De Costa B., Rice K.C. Sigma receptors. Biology and function Pharmacol. Rev. 42:1990;355-402.
28. Walker J.M., Matsumoto R.R., Bowen W.D., Gans D.L., Jones K.D., Walker F.O. Evidence for a role of haloperidol-sensitive σ-'opiate' receptors in the motor effects of antipsychotic drugs. Neurology. 38:1988;961-965.
29. Zhang J., Chiodo L.A., Wettstein J.G., Junien J.-L., Freeman A.S. Acute effects of sigma ligands on the electrophysiological activity of rat nigrostriatal and mesoaccumbal dopaminergic neurons. Synapse. 11:1992;267-278.